ストックスクリーナーアプリを入手
4.81
3.41%
-0.17
アフターアワーズ：
4.82
0.01
+0.21%
前日終値:
$4.98
開ける：
$4.98
24時間の取引高:
708.35K
Relative Volume:
0.53
時価総額：
$668.34M
収益：
-
当期純損益:
$-242.30M
株価収益率:
-1.9395
EPS:
-2.48
ネットキャッシュフロー:
$-192.10M
1週間 パフォーマンス:
-18.06%
1か月 パフォーマンス:
+7.85%
6か月 パフォーマンス:
-52.89%
1年 パフォーマンス:
-39.27%
1日の値動き範囲:
$4.81
$5.14
1週間の範囲:
$4.5505
$5.875
52週間の値動き範囲:
$3.72
$12.61
Cogent Biosciences Inc Stock (COGT) Company Profile
COGT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
4.81 | 668.34M | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-11 | ダウングレード | Needham | Buy → Hold |
| 2024-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | 開始されました | Citigroup | Buy |
| 2023-12-11 | ダウングレード | Wedbush | Outperform → Neutral |
| 2023-12-08 | 開始されました | JP Morgan | Overweight |
| 2023-04-28 | 開始されました | Robert W. Baird | Outperform |
| 2023-03-27 | 再開されました | H.C. Wainwright | Buy |
| 2022-12-14 | 開始されました | Needham | Buy |
| 2022-06-28 | 開始されました | Guggenheim | Buy |
| 2021-10-11 | 開始されました | H.C. Wainwright | Buy |
| 2021-06-09 | 再開されました | Jefferies | Buy |
| 2020-12-23 | 開始されました | Piper Sandler | Overweight |
| 2020-10-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Cogent Biosciences Inc (COGT) 最新ニュース
Robert W. Baird Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $7.00 - Defense World
Cogent Biosciences (NASDAQ:COGT) Releases Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Stock Surge: Cogent Biosciences Inc (COGT) Closes at 4.70, Marking a -15.62 Increase/Decrease - DWinneX
Cogent Biosciences (COGT) Maintains Neutral Rating Amid PT Adjustment | COGT Stock News - GuruFocus
Cogent Biosciences (COGT) Price Target Reduced by Baird | COGT Stock News - GuruFocus
MetLife Investment Management LLC Has $443,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Invesco Ltd. Sells 455,437 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Barchart.com
Wedbush Trims Price Target on Cogent Biosciences to $10 From $11, Maintains Neutral Rating - marketscreener.com
Cogent Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cogent Biosciences Inc (COGT) Q1 2025 Earnings: EPS Misses at -0 - GuruFocus
Cogent Biosciences (COGT) Plans Strategic Data Announcements in 2025 | COGT Stock News - GuruFocus
Cogent Biosciences Reports First Quarter 2025 Financial Results - GlobeNewswire
Form 424B5 Cogent Biosciences, Inc. - StreetInsider
Cogent Biosciences Gears Up for 3 Major Clinical Trial Readouts in 2025, Maintains Strong $245M Cash Reserve - Stock Titan
Wells Fargo & Company MN Acquires 14,413 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Advances with Promising Clinical Trials - TipRanks
(COGT) Trading Signals - news.stocktradersdaily.com
Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd. - Defense World
Barclays PLC Has $1.51 Million Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc [COGT] Records 200-Day SMA of $8.76 - knoxdaily.com
JPMorgan Chase & Co. Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - Sete News
Legal & General Group Plc Has $542,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc (COGT) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Financial Metrics Check: Cogent Biosciences Inc (COGT)’s Ratios for Trailing Twelve Months - DWinneX
Results from Cogent Biosciences Inc (COGT) show potential - uspostnews.com
Understanding the Risks of Investing in Cogent Biosciences Inc (COGT) - knoxdaily.com
Let’s Jump Into The Cogent Biosciences Inc (NASDAQ: COGT) Stock Forecast - Marketing Sentinel
Renaissance Technologies LLC Makes New Investment in Cogent Biosciences, Inc. (NASDAQ:COGT) - The AM Reporter
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Brokerages - Defense World
Cogent Appoints New Senior Executives to Lead Market Access and Corporate Strategy | COGT Stock News - GuruFocus
Cogent Biosciences Presents Four Posters at the American Associa - GuruFocus
Cogent Biosciences (COGT) Unveils Promising Preclinical Data on Cancer Inhibitors | COGT Stock News - GuruFocus
Cogent Biosciences, Inc. Unveils Preclinical Data from Four Pipeline Programs at AACR 2025 Annual Meeting - Nasdaq
Cogent Biosciences Presents Four Posters at the American - GlobeNewswire
Breakthrough: Cogent's Cancer Drug Achieves 90% Tumor Inhibition, Plus 3 More Pipeline Advances - Stock Titan
Cogent Biosciences Inc [COGT] Records 50-Day SMA of $6.47 - knoxdaily.com
Perhaps timely catching Cogent Biosciences Inc (COGT) would be a good idea - Sete News
Metric Analysis: Cogent Biosciences Inc (COGT)’s Key Ratios in the Limelight - DWinneX
Cogent Biosciences Inc (COGT) did well last session? - uspostnews.com
Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - knoxdaily.com
(COGT) Technical Data - news.stocktradersdaily.com
Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Insider Monkey
Geode Capital Management LLC Boosts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.
Vanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Wellington Management Group LLP Trims Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc (COGT) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):